Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-21 @ 1:34 AM
Study NCT ID:
NCT00038493
Status:
COMPLETED
Last Update Posted:
2018-10-29
First Post:
2002-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DM01-258
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None